Bethany Sensenig
Direttore Finanziario/CFO presso RADIUS HEALTH, INC.
Patrimonio netto: - $ in data 31/03/2024
Provenienza dei contatti di primo grado di Bethany Sensenig
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
202
| Public Company | Pharmaceuticals: Major | 202 |
Holding Company | Biotechnology | 17 | |
Public Company | Pharmaceuticals: Major | 15 | |
Public Company | Biotechnology | 11 | |
Naia Rare Diseases LLC
Naia Rare Diseases LLC Medical/Nursing ServicesHealth Services Naia Rare Diseases, Inc. develops pharmaceutical drugs for Short Bowel Syndrome (SBS) and other rare gastrointestinal diseases. The firm offers NB 1001 for adult SBS, NB 1001 for pediatric SBS, and NB 1002, a GLP-2 agonist. The company was founded by H. Daniel Perez and Mark Bagnall in 2014 and is headquartered in Cayman Islands.
2
| Subsidiary | Medical/Nursing Services | 2 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Bethany Sensenig tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
Biogen MA, Inc.
Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | Biotechnology | Human Resources Officer Corporate Officer/Principal Corporate Officer/Principal | |
ENZON PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Biotechnology | Chief Tech/Sci/R&D Officer Director/Board Member Director/Board Member | |
MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Sales & Marketing | |
NAVIDEA BIOPHARMACEUTICALS, INC. | Medical Specialties | Chairman Chairman | |
PFIZER, INC. | Pharmaceuticals: Major | General Counsel Corporate Officer/Principal Human Resources Officer | |
BOSTON SCIENTIFIC CORPORATION | Medical Specialties | Director of Finance/CFO Corporate Officer/Principal Public Communications Contact | |
SALIX PHARMACEUTICALS, LTD. | Pharmaceuticals: Major | Founder Director/Board Member Sales & Marketing | |
REVVITY, INC. | Medical Specialties | Director of Finance/CFO Director/Board Member Director/Board Member | |
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Biogen GmbH
Biogen GmbH Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen GmbH is a pioneer in the field of neuroscience since 1978. The company is based in Ismaning, Germany. Biogen focuses on research in therapeutic areas with a strong emphasis on difficult-to-treat diseases. The German company was founded in 1978 by Charles Weissman, Kenneth Murray, Heinz Schaller, Phillip Sharp, Walter Gilbert. The CEO is Michel Pericles Vounatsos. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Director/Board Member Chairman Director/Board Member Director/Board Member Director/Board Member Chief Executive Officer | |
Biogen Idec, Inc. (North Carolina)
Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen Idec, Inc. (North Carolina) is a pharmaceutical company based in Durham, NC. The company develops pharmaceutical products. Michel Pericles Vounatsos has been the CEO of the company since 2016. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Executive Officer Chief Executive Officer Director/Board Member Chief Operating Officer Director of Finance/CFO Chief Executive Officer | |
Massachusetts Institute of Technology | College/University | Corporate Officer/Principal Undergraduate Degree Undergraduate Degree Undergraduate Degree Graduate Degree Undergraduate Degree | |
Yale University | College/University | Undergraduate Degree Doctorate Degree Doctorate Degree Undergraduate Degree Doctorate Degree | |
BIOVERATIV INC | Biotechnology | Chairman Director/Board Member General Counsel Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal Director/Board Member Director/Board Member Corporate Officer/Principal | |
UNITY BIOTECHNOLOGY, INC. | Biotechnology | Comptroller/Controller/Auditor Director of Finance/CFO Chief Executive Officer Director/Board Member | |
Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin | |
Shire Pharmaceuticals, Inc.
Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | Pharmaceuticals: Major | General Counsel Corporate Officer/Principal Corporate Officer/Principal Sales & Marketing | |
THERMO FISHER SCIENTIFIC | Medical Specialties | Director/Board Member Director of Finance/CFO Corporate Officer/Principal | |
University of Massachusetts | College/University | Doctorate Degree Graduate Degree Undergraduate Degree | |
Anadys Pharmaceuticals, Inc.
Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ. | Pharmaceuticals: Major | Chairman Founder Director/Board Member | |
Columbia Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
EDITAS MEDICINE, INC. | Biotechnology | Chief Executive Officer Chief Executive Officer Chief Tech/Sci/R&D Officer | |
University of Maryland | College/University | Undergraduate Degree Undergraduate Degree Doctorate Degree | |
Harvard Medical School | College/University | Doctorate Degree Corporate Officer/Principal Corporate Officer/Principal | |
Bentley University | College/University | Graduate Degree Masters Business Admin Graduate Degree | |
RDD Pharma Ltd.
RDD Pharma Ltd. Medical SpecialtiesHealth Technology RDD Pharma Ltd. develops pharmacological treatments for diseases of the anorectal region. The company was founded by Nir Barak in 2008 and is headquartered in Ramat Hachayal, Israel. | Medical Specialties | Chairman Director/Board Member Chief Executive Officer | |
Bioverativ Therapeutics, Inc.
Bioverativ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Bioverativ Therapeutics, Inc. develops pharmaceutical products. It develops medicines for chronic diseases such as hemophilia, anemia, multiple sclerosis, and autoimmune disorders. The company is headquartered in Cambridge, MA. | Pharmaceuticals: Major | President Director/Board Member Director/Board Member | |
VERASTEM, INC. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
Aruna Bio, Inc.
Aruna Bio, Inc. Medical/Nursing ServicesHealth Services Aruna Bio, Inc. manufactures and provides neural stem cells. Its products include neuronet pure human neurons screening kit, neuronet pure human neurons discovery kit, co-culture kit hastropro-neuronet, hastropro human astrocytes kit and motor neurons GFP+htscreening kit. The company was founded by James Stice and Steven L. Stice in 2003 and is headquartered in Athens, GA. | Medical/Nursing Services | Chief Executive Officer Founder | |
TAKEDA PHARMACEUTICAL COMPANY LIMITED | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal | |
Sarissa Capital Management LP
Sarissa Capital Management LP Investment ManagersFinance Sarissa Capital Management LP (Sarissa) is an independent, SEC-registered investment advisor and hedge fund manager headquartered in Greenwich, Connecticut. The firm was founded in 2012 by Alexander Denner and Mayuran Sriskandarajah. Sarissa provides investment advisory services to pooled investment vehicles operating as private investment funds. | Investment Managers | Chief Executive Officer Founder | |
IRONWOOD PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member | |
Icahn Capital LP | Investment Trusts/Mutual Funds | Corporate Officer/Principal Corporate Officer/Principal | |
NIGHTSTAR THERAPEUTICS PLC | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
ADAMAS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | President Director/Board Member | |
The Johns Hopkins University School of Medicine | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
SCPHARMACEUTICALS INC. | Pharmaceuticals: Major | Director/Board Member Chairman | |
New York University | College/University | Undergraduate Degree Doctorate Degree | |
Boston University | College/University | Undergraduate Degree Masters Business Admin | |
Bryant University | College/University | Undergraduate Degree Masters Business Admin | |
CODIAK BIOSCIENCES | Pharmaceuticals: Major | General Counsel Corporate Officer/Principal | |
MIT Sloan School of Management | College/University | Masters Business Admin Masters Business Admin | |
BIODELIVERY SCIENCES INTERNATIONAL, INC. | Pharmaceuticals: Major | Chief Executive Officer Investor Relations Contact |
Statistiche
Distribuzione geografica
Stati Uniti | 44 |
Israele | 3 |
Marocco | 2 |
Germania | 2 |
Giappone | 2 |
Settori
Health Technology | 31 |
Consumer Services | 13 |
Finance | 4 |
Commercial Services | 3 |
Health Services | 2 |
Posizioni
Director/Board Member | 409 |
Corporate Officer/Principal | 231 |
Independent Dir/Board Member | 136 |
Undergraduate Degree | 82 |
Chairman | 78 |
Contatti più connessi
Insiders | |
---|---|
Eric Rowinsky | 36 |
Michael Rice | 33 |
Georges Gemayel | 33 |
George Scangos | 33 |
William Young | 32 |
Charles Newhall | 29 |
Hans-Peter Hasler | 28 |
Caroline Dorsa | 27 |
Stephen Sherwin | 26 |
Stelios Papadopoulos | 26 |
Alexander Denner | 25 |
Phillip Sharp | 20 |
Richard Mulligan | 19 |
Brian Posner | 19 |
Lorin Johnson | 19 |
- Borsa valori
- Insiders
- Bethany Sensenig
- Connessioni Società